These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8538722)

  • 1. Vaccination against influenza in healthy adults.
    Carrat F
    N Engl J Med; 1996 Feb; 334(6):403; author reply 403-4. PubMed ID: 8538722
    [No Abstract]   [Full Text] [Related]  

  • 2. Influenza vaccine for healthy adults.
    Schwartz K
    J Fam Pract; 1996 Apr; 42(4):351-2. PubMed ID: 8627201
    [No Abstract]   [Full Text] [Related]  

  • 3. Influenza vaccine for healthy adults?
    Patriarca PA; Strikas RA
    N Engl J Med; 1995 Oct; 333(14):933-4. PubMed ID: 7666882
    [No Abstract]   [Full Text] [Related]  

  • 4. Population-wide benefits of routine vaccination of children against influenza.
    Weycker D; Edelsberg J; Halloran ME; Longini IM; Nizam A; Ciuryla V; Oster G
    Vaccine; 2005 Jan; 23(10):1284-93. PubMed ID: 15652671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccination cost effective in U.S. adults.
    Geriatrics; 2006 Feb; 61(2):14. PubMed ID: 16502520
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccination against influenza in healthy adults.
    McCall TB
    N Engl J Med; 1996 Feb; 334(6):403-4. PubMed ID: 8538723
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccination against influenza in healthy adults.
    Small PA; Bender BS
    N Engl J Med; 1996 Feb; 334(6):402-3; author reply 403-4. PubMed ID: 8538721
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and economic impact of influenza vaccination on healthy children aged 2-5 years.
    Esposito S; Marchisio P; Bosis S; Lambertini L; Claut L; Faelli N; Bianchi C; Colombo GL; Principi N
    Vaccine; 2006 Jan; 24(5):629-35. PubMed ID: 16157429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
    Rothberg MB; Rose DN
    Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
    Newall AT; Scuffham PA; Kelly H; Harsley S; Macintyre CR
    Vaccine; 2008 Apr; 26(17):2142-53. PubMed ID: 18343537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and costs of immunizing children against influenza at school: an economic analysis based on a large-cluster controlled clinical trial.
    Schmier J; Li S; King JC; Nichol K; Mahadevia PJ
    Health Aff (Millwood); 2008; 27(2):w96-104. PubMed ID: 18216044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccination: cost-effective health care for the older adult?
    Hampson AW; Irving LB
    J Qual Clin Pract; 1997 Mar; 17(1):3-11. PubMed ID: 9107599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of influenza vaccination of healthy children.
    Salo H; Kilpi T; Sintonen H; Linna M; Peltola V; Heikkinen T
    Vaccine; 2006 Jun; 24(23):4934-41. PubMed ID: 16678945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.
    Maciosek MV; Solberg LI; Coffield AB; Edwards NM; Goodman MJ
    Am J Prev Med; 2006 Jul; 31(1):72-9. PubMed ID: 16777545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does cost savings mean cost effective?
    Finkelstein EA; Segel JE
    Am J Prev Med; 2010 Nov; 39(5):489-90. PubMed ID: 20965391
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of vaccination versus treatment of influenza in healthy adolescents and adults.
    Muennig PA; Khan K
    Clin Infect Dis; 2001 Dec; 33(11):1879-85. PubMed ID: 11692300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmaco-economics of anti-influenza vaccinations].
    Jahnz-Rózyk K
    Pol Merkur Lekarski; 2003 Jun; 14(84):679-81. PubMed ID: 14524303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of influenza vaccination in working-age cancer patients.
    Avritscher EB; Cooksley CD; Geraci JM; Bekele BN; Cantor SB; Rolston KV; Elting LS
    Cancer; 2007 Jun; 109(11):2357-64. PubMed ID: 17457827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against Hong Kong influenza in Japan.
    Fukumi H
    Bull World Health Organ; 1969; 41(3):555. PubMed ID: 5309473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.